Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial (Q33419283)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial |
scientific article |
Statements
1 reference
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial (English)
1 reference
National Cancer Institute of Canada Clinical Trials Group
1 reference
Sophie D Fossa
1 reference
Cora N Sternberg
1 reference
Laurence Collette
1 reference
Richard Sylvester
1 reference
J Martijn Kerst
1 reference
Iwona Skoneczna
1 reference
Peter Albers
1 reference
Mads Agerbaek
1 reference
Herlinde Dumez
1 reference
Maria de Santis
1 reference
Christine Théodore
1 reference
John D Chester
1 reference
Antony Verbaeys
1 reference
Lori Wood
1 reference
J Alfred Witjes
1 reference
Ronald de Wit
1 reference
Lionel Geoffrois
1 reference
Lisa Sengelov
1 reference
George Thalmann
1 reference
Danielle Charpentier
1 reference
Frédéric Rolland
1 reference
Laurent Mignot
1 reference
Paul Symonds
1 reference
John Graham
1 reference
Sandrine Marreaud
1 reference
European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group
1 reference
Groupe d'Etude des Tumeurs Urogénitales
1 reference
National Cancer Research Institute Bladder Cancer Study Group
1 reference
German Association of Urologic Oncology
1 reference
11 December 2014
1 reference
1 reference
16
1 reference
76-86
1 reference
Identifiers
1 reference
1 reference